endpoints.news is our new home on June 1. endpts.com will still work, but the front door is now https://endpoints.news

Two-thirds of re­cent rare dis­ease drugs re­lied on just one tri­al, plus con­fir­ma­to­ry ev­i­dence, FDA team finds

2 months ago
FDA+

No­vo Nordisk says new ear­ly R&D struc­ture will ‘fu­ture-proof’ its busi­ness

2 months ago
Pharma

Cal­ley Means joins White House as a spe­cial gov­ern­ment em­ploy­ee, will as­sist with MA­HA poli­cies

2 months ago
People

SV Health In­vestors nabs $250M to fund de­men­tia-fo­cused biotechs

2 months ago
Financing
Startups

Google is build­ing AI health­care helpers

2 months ago
Health Tech

As­cendis’ Chi­na joint ven­ture, Visen Phar­ma­ceu­ti­cals, prices $86M Hong Kong IPO

2 months ago
Financing
Startups

Mer­ck to lay off 163 work­ers in Penn­syl­va­nia; Del­pharm gets $60M from Cana­di­an gov­ern­ment 

2 months ago
Manufacturing

El­e­va­tion On­col­o­gy stops work on ADC, lays off work­ers; As­traZeneca’s CEPI fund­ing

2 months ago
News Briefing

Like its ri­vals, Op­tum Rx is chang­ing its pay­ment mod­els

2 months ago
Health Tech

Il­lu­mi­na was built on DNA. Its fu­ture could be bi­ol­o­gy’s next big wave

2 months ago
In Focus
Diagnostics

Up­dat­ed: Monte Rosa re­ports first da­ta for mol­e­c­u­lar glue pro­gram li­censed to No­var­tis

2 months ago
R&D

Paratek boosts com­mer­cial port­fo­lio in move to buy Opti­nose and its nasal spray

2 months ago
Deals
Pharma

Sanofi to pay $600M up­front for Dren Bio’s bis­pe­cif­ic B cell de­pleter

2 months ago
Deals

A Cal­i­for­nia health tech com­pa­ny is let­ting AI run med­ical vis­its, from in­take to di­ag­no­sis

2 months ago
AI
In Focus

No­var­tis touts Zol­gens­ma da­ta in old­er kids as it read­ies reg­u­la­to­ry fil­ings

2 months ago
Pharma

Gilead stock slips as HHS de­nies re­ports of HIV fund­ing cuts

2 months ago
Pharma
Law

DOJ lawyers de­fend abor­tion pill re­stric­tions in new court fil­ing

2 months ago
FDA+
Law

Car­go Ther­a­peu­tics scraps R&D pipeline, ax­es bulk of work­force as it looks for an ex­it

2 months ago
People
R&D

Ahead of FDA de­ci­sion, Al­ny­lam faces the big ques­tion: Can it make mon­ey?

2 months ago
Pharma
FDA+

Re­genxbio shares new Duchenne gene ther­a­py da­ta ahead of big read­out next year

2 months ago
R&D

Pfiz­er ful­ly ex­its Sen­so­dyne mak­er Ha­le­on in $3.3B stake sale

2 months ago
Pharma

Up­dat­ed: Im­muno­vant will not take rare dis­ease drug to reg­u­la­tors de­spite Phase 3 win

2 months ago
R&D

Roche inks $1B+ biobucks deal with UK biotech for new an­ti­body can­cer tar­gets

2 months ago
Deals
R&D

Flag­ship's Am­per­sand gets Eli Lil­ly's sup­port in $65M Se­ries B

2 months ago
Financing
Startups
First page Previous page 26272829303132 Next page Last page
A service from the Financial Times